SGS Canada Inc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Canada
- Registered address
- 6490 Vipond Dr, Mississauga, Ontario L5T 1W8, Canada (CAN)
- Operations here
- analysis
- FDA identifiers
- FEI 3007632373 · DUNS 203668041
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2023-11-15
- NAIDrug Quality Assurance2019-10-16
- VAIDrug Quality Assurance2017-12-12
- VAIDrug Quality Assurance2016-09-16
- NAIDrug Quality Assurance2014-06-20
- VAIDrug Quality Assurance2012-07-20
- VAIDrug Quality Assurance2009-12-10
Drugs this plant is listed as making
4 distinct drugs across 4 products name this site in their FDA label.
- amifampridine phosphateCatalyst Pharmaceuticals, Inc.
- sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphateLukare Medical, LLC
- Sodium ChlorideBaxter Healthcare Company
- zopapogene imadenovecPrecigen, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.